ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -16.7% | 50,000 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $12,000 | -64.7% | 50,000 | -18.0% | 0.00% | -33.3% |
| Q4 2021 | $34,000 | -27.7% | 61,000 | +32.6% | 0.00% | -40.0% |
| Q3 2021 | $47,000 | -17.5% | 46,000 | +12.2% | 0.01% | -16.7% |
| Q2 2021 | $57,000 | +32.6% | 41,000 | +60.8% | 0.01% | 0.0% |
| Q1 2021 | $43,000 | +38.7% | 25,500 | +2.0% | 0.01% | +50.0% |
| Q4 2020 | $31,000 | +10.7% | 25,000 | +25.0% | 0.00% | -20.0% |
| Q3 2020 | $28,000 | +16.7% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $24,000 | 0.0% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $24,000 | -31.4% | 20,000 | +100.0% | 0.01% | -33.3% |
| Q1 2019 | $35,000 | +52.2% | 10,000 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $23,000 | -72.0% | 10,000 | -59.0% | 0.01% | -69.6% |
| Q2 2018 | $82,000 | – | 24,393 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $17,037,000 | 0.97% |
| WealthTrust Axiom LLC | 140,000 | $441,000 | 0.16% |
| Palo Alto Investors LP | 1,032,715 | $3,253,000 | 0.15% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $157,000 | 0.08% |
| Joel Isaacson & Co., LLC | 80,660 | $254,000 | 0.05% |
| Malaga Cove Capital, LLC | 10,250 | $31,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $95,000 | 0.02% |
| Granahan Investment Management | 31,298 | $99,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,150 | $769,000 | 0.01% |
| Advisor Group, Inc. | 117,657 | $371,000 | 0.01% |